WHCA Webinar: Continuing Medications to Treat Opioid Use Disorder in Post-Acute Care Settings - Clinical and Regulatory Considerations & Updates to Know About in 2023 | AL/ESF/SNF

Thursday, August 17, 2023

COURSE OVERVIEW

You are in a post-acute care setting, and you need to admit a patient on buprenorphine or methadone—what now? There have been many profound regulatory and clinical best practice updates in recent years at the state and federal levels regarding how to best manage patients who have substance use disorders in post-acute care settings. Please join the Washington State Opioid Treatment Authority Jessica Blose to discuss these updates and what your organization needs to know in order to work successfully with patients and comply with current regulatory bodies and payor system requirements. Washington State is experiencing the highest number of fatal opioid overdose deaths in our state’s history. Post-acute care settings have been identified as extremely important partners in helping Washingtonians with a substance use disorder. Please come to this session and learn about how your post-acute care setting can help play a key role in combatting the opioid epidemic here in Washington State!

REGISTRATION INFORMATION

$39 per facility              WHCA Member Rate

$78 per facility              Non-WHCA Member Rate

You may have as many people join in as you would like—one phone/computer may log in per registration! Please register only one person for the webinar unless a second individual plans to log in from a separate location.

Login and dialing instructions will be emailed on the day prior to the webinar.

Two CEUs will be granted to each individual who completes the live webinar presentation.

SPEAKER

Jessica Blose, CDP, LMHC, NCC, MAC, CCMHC

Jessica Blose, LMHC, SUDP, NCC, CCMHC, currently serves as the State Opioid Treatment Authority for Washington State. Jessica also holds a concurrent position as Manager of Behavioral Health Clinical Support for the Washington State Health Care Authority. Prior to her current roles, Jessica also worked as a regulator of licensing and certification for mental health and substance use disorder behavioral health agencies within Washington State with the Washington Division of Behavioral Health and Recovery. Before coming to Washington State, Jessica spent her direct service counseling career in New York State, holding a variety of clinical and administrative positions in integrated, co-occurring behavioral health treatment agencies that also operated both opioid treatment programs and office-based opioid treatment programs. Jessica maintains active licensure as a mental health and substance use counselor in Washington State. Jessica also holds both an MS in Mental Health Counseling; and an EdM in School Counseling from the SUNY University at Buffalo in New York State.